Specific chapters in this book discuss mutations in genes associated with an OI phenotype where, to date, only one clinical example has been identified. While the majority of mutations involve genes related to type I collagen synthesis, application of new gene sequencing technology has revealed involvement in metabolic systems related to osteoblast maturation and osteoblast activity that were previously unsuspected. The purpose of this closing section of this book is to describe involvement of genes related to an osteogenesis imperfecta (OI) phenotype that were not known as development of this book progressed. The inclusion of TMEM3B and Wnt1 genotypes/phenotypes, aside from their genetic and clinical importance, merely serves to keep the door open for discoveries yet to come.
|Original language||English (US)|
|Title of host publication||Osteogenesis Imperfecta|
|Subtitle of host publication||A Translational Approach to Brittle Bone Disease|
|Number of pages||3|
|State||Published - Sep 1 2013|
- Osteoblast differentiation
ASJC Scopus subject areas